|
|||||
|
|
Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening |
|
| Authors: | Robert A. Smith PhD Deana Manassaram‐Baptiste MPH PhD Durado Brooks MD MPH Mary Doroshenk MA Stacey Fedewa MPH Debbie Saslow PhD Otis W. Brawley MD Richard Wender MD |
| Affiliation: | 1. Senior Director for Cancer Screening, Cancer Control Department, American Cancer Society, Atlanta, GA;2. Research Scientist, Cancer Control Department, American Cancer Society, Atlanta, GA;3. Director of Colorectal and Prostate Cancer, Cancer Control Department, American Cancer Society, Atlanta, GA;4. Director, National Colorectal Cancer Roundtable, American Cancer Society, Atlanta, GA;5. Director for Risk Factor Screening and Surveillance, Department of Epidemiology and Research Surveillance, American Cancer Society, Atlanta, GA;6. Director of Breast and Gynecological Cancer, Cancer Control Department, American Cancer Society, Atlanta, GA;7. Chief Medical Officer, American Cancer Society, Atlanta, GA;8. Chief Cancer Control Officer, American Cancer Society, Atlanta, GA |
| Abstract: | Answer questions and earn CME/CNE Each year, the American Cancer Society (ACS) publishes a summary of its guidelines for early cancer detection along with a report on data and trends in cancer screening rates and select issues related to cancer screening. In this issue of the journal, we summarize current ACS cancer screening guidelines. The latest data on utilization of cancer screening from the National Health Interview Survey (NHIS) also is described, as are several issues related to screening coverage under the Affordable Care Act, including the expansion of the Medicaid program. CA Cancer J Clin 2015;65:30–54. © 2015 American Cancer Society. |
| Keywords: | mass screening prevention and control practice guidelines neoplasms mortality breast radiography stool test colonoscopy Papanicolaou test prostate‐specific antigen test |